VALIDATION IMAGES
Paraformaldehyde-fixed and paraffin-embedded Rat Lung tissue incubated with EPAS1 (2G3) Monoclonal Antibody (bsm-54278R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Breast Cancer tissue incubated with EPAS1 (2G3) Monoclonal Antibody (bsm-54278R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Human Placenta tissue incubated with EPAS1 (2G3) Monoclonal Antibody (bsm-54278R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Paraformaldehyde-fixed and paraffin-embedded Mouse Colon tissue incubated with EPAS1 (2G3) Monoclonal Antibody (bsm-54278R) at 1:100, overnight at 4°C, followed by a conjugated secondary antibody and DAB staining. Counterstained with hematoxylin.
Flow cytometric analysis of HUVEC cells with EPAS1 (2G3) Monoclonal Antibody (bsm-54278R) at a 1:100 dilution (red) compared with an unlabeled control (cells without incubation with primary antibody; black).
Lane 1: Mouse Lung tissue lysates; Lane 2: Mouse Placenta tissue lysates; Lane 3: Mouse Testis tissue lysates; Lane 4: Rat Testis tissue lysates ; Lane 5: Human HepG2 cell lysates; Lane 6:Human MCF-7 cell lysates; Lane 7: Human U87MG cell lysates; Lane 8: Human SH-SY5Y cell lysates probed with EPAS1 (2G3) Monoclonal Antibody, Unconjugated (bsm-54278R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.